Market Cap 8.38M
Revenue (ttm) 2.89M
Net Income (ttm) -11.02M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -381.31%
Debt to Equity Ratio 0.02
Volume 24,300
Avg Vol 125,086
Day's Range N/A - N/A
Shares Out 2.76M
Stochastic %K 83%
Beta 0.65
Analysts Sell
Price Target $28.00

Company Profile

Sintx Technologies, Inc., an advanced ceramics company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, technical, and antipathogenic applications in the United States. The company offers solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials, polyether ether ketone, and polyetherketoneketone. The company was formerly known as Am...

Industry: Medical Devices
Sector: Healthcare
Phone: 801 839 3500
Address:
1885 West 2100 South, Salt Lake City, United States
MathiasMatheson
MathiasMatheson Aug. 19 at 10:48 AM
$SINT should be getting that ankle fda clearance any day now
0 · Reply
Boston7452
Boston7452 Aug. 16 at 5:38 PM
$SINT If TA&T was unloaded because it isnt a core business than that means Sintx Armor is still a core business even if shuttered…for now. that still implies Sintx-NP Aerospace relationship.
1 · Reply
Boston7452
Boston7452 Aug. 15 at 7:57 PM
$SINT i assume the 500k research collab is with Dr Sonny Ball former CEO as he did that sort of thing before and while CEO.
1 · Reply
Boston7452
Boston7452 Aug. 15 at 4:49 PM
$SINT Cant commercialize without its partners coming into the light, it doesnt have the sales infrastructure. Come out come out...Right now it needs a PPE partner to come out because COVIDS getting worse again. Fall/Winter wave will be worse than Summer and likely get worse year over year for the next several years: "Future waves could become more severe "
2 · Reply
Boston7452
Boston7452 Aug. 15 at 3:12 PM
$SINT “commercialization strategy designed to deliver breakthrough medical solutions and create substantial shareholder value.” The values already there just not reflected by the markets. Sintx is sitting on billion dollar IP and worth 7m according to the markets?
0 · Reply
amda
amda Aug. 15 at 2:09 PM
$SINT well, at least this guy is more talkative than Sonny the Shareholder Slayer....
1 · Reply
Boston7452
Boston7452 Aug. 14 at 9:18 PM
$SINT Seems like an arbitrary amount of shares repurchased, but ~50k so far. 04/01/25 – 04/30/25 20,759 $ 2.25 03/01/25 – 03/31/25 29,665 $ 2.91
0 · Reply
Boston7452
Boston7452 Aug. 13 at 5:17 AM
$SINT finally Si3N4 is getting the right attention on the PPE front. One of the researchers on this new study is very experienced in Virology doing several projects for the DoD over the years, Dr. Kylene Kehn-Hall.
0 · Reply
Boston7452
Boston7452 Aug. 12 at 10:09 PM
$SINT I keep asking wheres PPE? Especially considering COVID is on the rise again. "The most promising finding was the significant reduction of SARS-CoV-2 after only 10 minutes of exposure to refined α-Si₃N₄-embedded fabric. Silicon nitride could prove to be an invaluable inorganic additive in personal protective equipment during future viral epidemics and pandemics."
3 · Reply
Boston7452
Boston7452 Aug. 12 at 6:55 PM
$SINT Anyone else think Boston Scientific is keeping an eye on Sintx-NedMedical JDA via Mr. Anderson?
4 · Reply
Latest News on SINT
SINTX Technologies Announces Stock Repurchase Program

Nov 18, 2024, 6:00 AM EST - 9 months ago

SINTX Technologies Announces Stock Repurchase Program


SINTX Technologies to Explore Strategic Opportunities

Jun 18, 2024, 9:00 AM EDT - 1 year ago

SINTX Technologies to Explore Strategic Opportunities


MathiasMatheson
MathiasMatheson Aug. 19 at 10:48 AM
$SINT should be getting that ankle fda clearance any day now
0 · Reply
Boston7452
Boston7452 Aug. 16 at 5:38 PM
$SINT If TA&T was unloaded because it isnt a core business than that means Sintx Armor is still a core business even if shuttered…for now. that still implies Sintx-NP Aerospace relationship.
1 · Reply
Boston7452
Boston7452 Aug. 15 at 7:57 PM
$SINT i assume the 500k research collab is with Dr Sonny Ball former CEO as he did that sort of thing before and while CEO.
1 · Reply
Boston7452
Boston7452 Aug. 15 at 4:49 PM
$SINT Cant commercialize without its partners coming into the light, it doesnt have the sales infrastructure. Come out come out...Right now it needs a PPE partner to come out because COVIDS getting worse again. Fall/Winter wave will be worse than Summer and likely get worse year over year for the next several years: "Future waves could become more severe "
2 · Reply
Boston7452
Boston7452 Aug. 15 at 3:12 PM
$SINT “commercialization strategy designed to deliver breakthrough medical solutions and create substantial shareholder value.” The values already there just not reflected by the markets. Sintx is sitting on billion dollar IP and worth 7m according to the markets?
0 · Reply
amda
amda Aug. 15 at 2:09 PM
$SINT well, at least this guy is more talkative than Sonny the Shareholder Slayer....
1 · Reply
Boston7452
Boston7452 Aug. 14 at 9:18 PM
$SINT Seems like an arbitrary amount of shares repurchased, but ~50k so far. 04/01/25 – 04/30/25 20,759 $ 2.25 03/01/25 – 03/31/25 29,665 $ 2.91
0 · Reply
Boston7452
Boston7452 Aug. 13 at 5:17 AM
$SINT finally Si3N4 is getting the right attention on the PPE front. One of the researchers on this new study is very experienced in Virology doing several projects for the DoD over the years, Dr. Kylene Kehn-Hall.
0 · Reply
Boston7452
Boston7452 Aug. 12 at 10:09 PM
$SINT I keep asking wheres PPE? Especially considering COVID is on the rise again. "The most promising finding was the significant reduction of SARS-CoV-2 after only 10 minutes of exposure to refined α-Si₃N₄-embedded fabric. Silicon nitride could prove to be an invaluable inorganic additive in personal protective equipment during future viral epidemics and pandemics."
3 · Reply
Boston7452
Boston7452 Aug. 12 at 6:55 PM
$SINT Anyone else think Boston Scientific is keeping an eye on Sintx-NedMedical JDA via Mr. Anderson?
4 · Reply
Boston7452
Boston7452 Aug. 12 at 6:16 PM
$SINT Busy last couple of years on the patent front. First with a collection of Antipathogenic patents, followed by patents relating to coatings of other so called biomaterials, and finally patent for agricultural uses of Si3n4.
3 · Reply
Boston7452
Boston7452 Aug. 12 at 2:47 PM
$SINT 1 year with new CEO and nothings changed on the business front.
1 · Reply
MathiasMatheson
MathiasMatheson Aug. 12 at 11:12 AM
$SINT nvm error on my part
0 · Reply
MathiasMatheson
MathiasMatheson Aug. 12 at 10:20 AM
$SINT why are the new fillings all july 31 ?
0 · Reply
JoseGilberto109
JoseGilberto109 Aug. 8 at 11:16 PM
Wow what is happening to SNSE right now!? Seems like ALL volume and momentum are shifting into SNSE!! Could it be the next crazy runner of the day?? Only 500k float on SNSE - Bulls should keep it on watch!! Also watching: $ALLR $SINT $SNTG $SNTI bio
0 · Reply
2TrustHim
2TrustHim Aug. 8 at 5:34 PM
$SINT Where is this going before Huge Partnerships or Maybe BO???!!!
1 · Reply
Boston7452
Boston7452 Aug. 6 at 5:43 PM
$SINT This is what happens when you depend on computers due to their tendency to glitch, it goes haywire and tries to kill you. AI, etc.. not the solution but will be a growing problem. Only thing missing from this image is a fire under musk to illustrate thermal runaway.
3 · Reply
GaryCruz244
GaryCruz244 Aug. 6 at 5:01 PM
$SINT is exploring biopolymer uses, while AITX is exploring market dominance in AI-powered guarding.
0 · Reply
amda
amda Aug. 5 at 7:14 PM
$SINT bought. on pump watch....
0 · Reply
Boston7452
Boston7452 Aug. 5 at 3:12 PM
$SINT Wheres PPE (air filtration included)? what about Wound care? Catheters? Those all seem like fairly easy products to develop once the method for imbuing was determind years ago. So many products developed and delayed.
2 · Reply
Boston7452
Boston7452 Aug. 5 at 3:47 AM
$SINT This is the study im waiting to see the results of, due soon. “In Phase II, SINTX and external collaborators will conduct formal design validation activities; test static and dynamic mechanical properties of implants 3DP according to the revised design; carry out formal biocompatibility assessments; and assess in vivo antimicrobial activity, biocompatibility, and osseointegration for a 3DP SN-PEEK cervical implant against appropriate controls.”
1 · Reply
amda
amda Aug. 4 at 2:35 PM
$SINT nice ask slapping....
0 · Reply